Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

The deal is AstraZenecas second this month after it agreed last week to buy Amolyt Pharma for $1.05 billion to…

…

AstraZeneca Plc agreed to buy Fusion Pharmaceuticals Inc. for as much as $2.4 billion as it seeks to transform cancer…

AstraZeneca to buy Fusion Pharma for $2 billion in cash…

19 March 2024 AstraZeneca to acquire Fusion to accelerate the development of next-generation radioconjugates to treat cancer Includes actinium-based clinical-stage radioconjugate targeting PSMA…

AstraZeneca caps inhaler costs at $35 for eligible US patients…

AstraZeneca to cap US out-of-pocket costs for inhalers at $35 per month…

Kommunen fordern "Atempause" bei Flüchtlingen ++ EU schließt 7,4-Milliarden-Flüchtingsdeal mit Ägypten ++ Teilurteil in Corona-Prozess gegen AstraZeneca erwartet ++ neue…

AstraZeneca (AZN) is set to buy a private rare disease drugmaker. FDA delays decision on Lillys (LLY) donanemab and approves…

Kulmbach (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie des…

A rash of dealmaking helped reverse the declining fortunes of biotech stocks over the last five months. And as AstraZeneca…

Frankfurt (www.aktiencheck.de) - Rating-Update: Die Analysten von ODDO BHF stufen die Aktie von AstraZeneca plc (ISIN: GB0009895292, WKN: 886455, Ticker-Symbol: ZEG,…

AstraZeneca will acquire Amolyt Pharma for up to $1.05 billion in total consideration…

AstraZeneca to buy Amolyt Pharma for $1.05 billion to boost rare diseases portfolio…

14 March, 2024 AstraZeneca to acquire Amolyt Pharma, expanding late-stage rare disease pipeline Amolyt development portfolio includes Phase III asset with potential to address…

AstraZeneca (AZN) enters into an agreement to acquire Amolyt Pharma to strengthen its rare disease pipeline by adding the latters…

The Global Recombinant Vaccine Market Size was Valued at USD 8.2 Billion in 2023 and the Worldwide Recombinant Vaccine Market…

Companies covered in this study are Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc (GSK), AstraZeneca plc, Novartis AG, Johnson…

AstraZeneca CEO Pascal Soriot, who has been critical of the U.K.’s business environment for the life sciences industry, is directing…

AstraZeneca to invest 650 million pounds in UK to boost pandemic preparedness…

New York (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von Guggenheim Securities: Die Analysten von Guggenheim Securities stufen die Aktie von AstraZeneca plc (ISIN: GB0009895292,…

4 March 2024 Two datopotamab deruxtecan applications validated in the EU for patients with advanced nonsquamous non-small cell lung cancer or HR-positive, HER2-negative…

U.S. District Judge Colm Connollys decision comes one day before manufacturers have to respond to Medicares initial price offers for…

1 March 2024 15:00 GMT Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct…

Costco Wholesale, The Walt Disney, AstraZeneca, OReilly Automotive and Restaurant Brands International are part of the Zacks top Analyst Blog.…

Todays Research Daily features new research reports on 16 major stocks, including Costco Wholesale Corporation (COST), The Walt Disney Company…

Since Prime Minister Margaret Thatcher unleashed a wave of privatizations in the 1980s, the London Stock Exchange has been a…

Aradhana Sarin led deals to expand AstraZenecas drug pipeline, and transformed the finance function to improve employee retention and productivity.…

The FibroGen – AstraZeneca China Agreement for Roxadustat remains in place …

…

…

SAN DIEGO and SUZHOU, China and SHANGHAI, China, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (“Gracell”…

22 February 2024 Acquisition of Gracell completed AstraZeneca today announced the successful completion of the acquisition (https://www.astrazeneca.com/media-centre/press-releases/2023/astrazeneca-to-acquire-gracell-furthering-cell-therapy-ambition-across-oncology-and-autoimmune-diseases.html) of Gracell Biotechnologies Inc. (Gracell, NASDAQ: GRCL), a…

22 February 2024 11:00 GMT Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announced that, on 20 February 2024, an…

…

Sodexo and AstraZeneca extend their global partnership for a further 5 years.…

22 February 2024 07:00 GMT AstraZeneca prices a $5bn bond offering AstraZeneca PLC ("AstraZeneca") announces that its wholly owned subsidiary AstraZeneca Finance LLC, priced…

21 February 2024 07:00 GMT Filing of Annual Report on Form 20-F with the US Securities and Exchange Commission AstraZeneca PLC (the Company) announced…

Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Global Incretin Based Drugs Market (2023 Edition): Analysis By Drug…

Hamburg (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von Berenberg: Luisa Hector, Analystin von Berenberg, stuft die Aktie des britisch-schwedischen Pharmakonzerns AstraZeneca plc (ISIN: GB0009895292,…

1. Currys rejects low-ball £700mln offer, second bid emerges Currys PLC (LSE:CURY) rejected an unsolicited £700 million takeover offer from…

19 February 2024 Acquisition of Icosavax Completed AstraZeneca announced today the successful completion of the acquisition of Icosavax, Inc., a US-based clinical-stage…

…

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Astrazeneca auf "Sell" mit einem Kursziel von 9900 Pence belassen. Die…

Currys takeover bid rejected Moneysupermarket nets strong insurance earnings FTSE 100 opens lower, AstraZeneca surges 8.30am: AstraZeneca seen higher...…

FTSE 100 up 21 points at 7,733. AstraZeneca, Rolls-Royce gain. Germany said to already be in recession. 3.57pm: Germany likely in recession -…

FTSE 100 up 6 points at 7,717. Currys takeover bid rejected. AstraZeneca surges. 10.44am: Gas slips on mild weather, oil continues to recede…

Currys takeover bid rejected Moneysupermarket nets strong insurance earnings FTSE 100 opens lower, AstraZeneca surges 9.16am: House prices see first…

FTSE 100 up 10 points at 7,722. Currys centre of bidding war. AstraZeneca, Rolls-Royce surge. 11.33am: AstraZeneca, Rolls-Royce lead risers AstraZeneca led...…

FTSE 100 up 6 points at 7,718. Currys takeover bid rejected. AstraZeneca surges. 9.50am: AstraZeneca: UBS sees sales boost from latest treatments As...…